Congenital, Hereditary, and Neonatal Diseases and Abnormalities Clinical Trials in Hillsborough, North Carolina

Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)